PD-1

Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

HARMONi-6 marks the first phase 3 trial in which a regimen has beaten the combination of a PD-1 inhibitor and chemotherapy on PFS in first-line NSCLC.

Angus Liu Oct 19, 2025 10:45am

Gilead, Arcus keep TIGIT dream alive with 27-month OS data

Oct 13, 2025 7:05am

White arrow on a road pointing to the rising sun

Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

Apr 28, 2025 7:25am

blocks stack target climb build arrow meet

AnaptysBio's PD-1 drug reduces rheumatoid arthritis in phase 2

Feb 12, 2025 9:57am

Will Novartis catch the PD-1 bispecific wave? CEO weighs in

Jan 31, 2025 3:30am

Soccer ball flying into a net scoring a goal

Pfizer's PD-1 prospect hits goal in phase 3 bladder cancer study

Jan 10, 2025 6:45am